Glucotrack (GCTK) announced that David Hirsh, has joined the Company’s clinical advisory team as Medical Director – Cardiology, providing strategic leadership for clinical and educational initiatives for the Continuous Blood Glucose Monitor. Since early 2025, he has been a cardiac electrophysiologist at Harbin Clinical Cardiology Rome.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GCTK: